Diabetes and Hypertension
Diabetes and Hypertension
Part of NephTimes Diseases and Conditions
Advertisement
Victoria SochaDiabetes and Hypertension | September 18, 2023
The prevalence of CKD and cost of screening were the most influential parameters.
Read More
Victoria SochaDiabetes and Hypertension | September 18, 2023
A report on outcomes of kidney transplant recipients treated with SGLT2 inhibitors.
Victoria SochaDiabetes and Hypertension | September 11, 2023
The predictive power of ESRD progression was high with choline, myo-inositol, and citrate.
Victoria SochaDiabetes and Hypertension | September 7, 2023
The odds of being prescribed newer second-line diabetes medications decreased with increasing age.
Victoria SochaKidney Transplantation | August 31, 2023
The most common primary renal disease in patients initiating renal replacement therapy is diabetes.
Victoria SochaDiabetes and Hypertension | August 28, 2023
Several classes of glucose-lowering drugs have been shown to have kidney benefits in patients with type 2 diabetes.
Victoria SochaDiabetes and Hypertension | August 3, 2023
The most common concomitant medication classes were antihypertensives (95%), antihyperglycemic (81%), and statins (79%).
Victoria SochaDiabetes and Hypertension | August 3, 2023
Preliminary evidence has demonstrated preservation of kidney function as measured by eGFR compared with baseline.
Victoria SochaDiabetes and Hypertension | June 22, 2023
There was a significant decrease in blood pressure control from 77.6% in 2012 to 74.5% in 2016 and 67.7% in 2020.
Victoria SochaDiabetes and Hypertension | June 1, 2023
Assessing the early impact of risk categorization on management of patients with DKD.
Victoria SochaDiabetes and Hypertension | May 31, 2023
Gaps in care in treating proteinuria in patients with DKD.
Victoria SochaDiabetes and Hypertension | May 15, 2023
Depressive symptoms and adherence to BP goals in SPRINT.
Victoria SochaDiabetes and Hypertension | May 15, 2023
The effect of blood pressure on cognitive outcomes might be modified by baseline depressive symptoms.
Victoria SochaDiabetes and Hypertension | May 13, 2023
Patients with end-stage renal disease on maintenance hemodialysis commonly develop hyperphosphatemia, a complication ...
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | April 18, 2023
Sodium-glucose transport protein 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, block SGLT2 cotransporters in the ...
Victoria SochaDiabetes and Hypertension | April 18, 2023
There is an association  between type 2 diabetes and a higher risk of developing kidney failure. Helena Bleken ...
Victoria SochaNKF Spring Clinical Meetings 2023 | April 13, 2023
Complications associated with living kidney donation include hypertension. However, according to Ekamol Tantisattamo, ...
Victoria SochaNephrology Times | March 20, 2023
In the population of patients with chronic kidney disease (CKD), particularly those with diabetes as the underlying ...
Victoria SochaDiabetes and Hypertension | March 9, 2023
In patients with type 2 diabetes, ectopic fat is a major pathogenic factor. According to Niels Sondergaard Heinrich, MD, ...
Victoria SochaDiabetes and Hypertension | March 9, 2023
Screening recommendations for kidney disease include annual testing for albuminuria following 5 years duration of type 1 ...
Advertisement
Advertisement
Advertisement
Latest News

September 22, 2023